Noreen Krall, who served as vice president and chief litigation counsel for more than a decade and helped build the company’s reputation as a fierce courtroom opponent, left Apple in December, IAM has learned
Case filed yesterday by the iPhone giant makes clear that it wants its patent licensing dispute with the Swedish company to centre on the US court system
SCOTUS refuses to consider NHK-Fintiv legal challenges, with significant implications for PTAB actions
Increased fees helped the office's budget escape unscathed from a drop in applications, and the agency expects 1.5% growth in patenting this year
19 January 2022
Nader Mousavi, Mehdi Ansari, Jay Thornton and Jonathan Hofman of Sullivan & Cromwell explore the legal issues facing creators and buyers of NFTs, alongside the regulatory frameworks in which they are being used
19 January 2022
African tech transfer hub is making fast progress in replicating the approved mRNA jab
18 January 2022
Swedish telco asserts patents against the iPhone maker in the Western District of Texas and at least one jurisdiction outside the US
18 January 2022
Finnegan attorneys Erik Puknys and Michelle Rice explain that while the proposed DOJ/NIST/USPTO FRAND framework is good for implementers, it may not be enough to make the US stand out in global forum competition
17 January 2022
Sonos’s recent win over Google at the ITC demonstrates the importance of innovators having the ability to exclude infringers from practising on their inventions
14 January 2022
A district court judge has thrown out an induced infringement allegation against Hikma Pharmaceutical, but big questions remain over drug label carve-outs
14 January 2022
SEP licensors will have to look again at duplicate royalty reimbursement policies following first-of-a-kind ruling
13 January 2022
Shell company’s validity challenge threatens the eye-watering damages award and Fortress-backed entity says it could open the door to abuse of the PTAB system
12 January 2022
The Long Read: Jeffrey Morton and Thomas Ehrich unpack the complex patent considerations surrounding one of the most important leaps forward in biotechnology
12 January 2022
Get unlimited access to all IAM content
